Status:
COMPLETED
Biomolecular Phenotyping of Lung Transplant Recipients
Lead Sponsor:
Policlinico Hospital
Collaborating Sponsors:
University of Milan
Conditions:
Lung Transplant Failure
Eligibility:
All Genders
18+ years
Brief Summary
Primary graft dysfunction (PGD) is a common problem after a lung transplant. It's a sudden lung injury that affects around 30% of patients within 72 hours of getting a new lung. PGD can vary in severi...
Detailed Description
Primary graft dysfunction (PGD) is the most common complication after lung transplant (LUTX). PGD is an acute form of lung injury with an incidence of 30%, defined upon alteration of oxygenation and r...
Eligibility Criteria
Inclusion
- undergone double LUTX
- age \> 18 years old
Exclusion
- single LUTX
- re-transplantation
Key Trial Info
Start Date :
February 1 2022
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 1 2025
Estimated Enrollment :
80 Patients enrolled
Trial Details
Trial ID
NCT06125535
Start Date
February 1 2022
End Date
June 1 2025
Last Update
June 18 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Fondazione IRCCS Ca'Granda - Ospedale Maggiore Policlinico
Milan, Milan, Italy, 20122